Glen Edward Foster

Glen Edward Foster

Auto-generated profile, based on publicly available information

Glen Edward Foster

University of British Columbia

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2005 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Open access
PDF file
GFG. E. Foster
G. E. Foster
ASA. W. Sheel
A. W. Sheel
The purpose of this review is to outline the physiological responses associated with the diving response, its functional significance, and its cardiorespiratory control. This review is separated into four major sections. Section one outlines the diving response and its physiology. Section two provides support for the hypothesis that the primary role of the diving response is the conservation of oxygen. The third section describes how the diving response is controlled and provides a model that illustrates the cardiorespiratory interaction. Finally, the fourth section illustrates potential adaptations that result after regular exposure to an asphyxic environment. The cardiovascular and endocrine responses associated with the diving response and apnea are bradycardia, vasoconstriction, and an increase in secretion of suprarenal catecholamines. These responses require the integration of both the cardiovascular system and the respiratory system. The primary role of the diving response is likely to conserve oxygen for sensitive brain and heart tissue and to lengthen the time before the onset of serious hypoxic damage. We suggest that future research should be focused towards understanding the role of altered ventilatory responses in human breath‐hold athletes as well as in patients suffering from sleep‐disordered breathing.

15 November 2009 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
VPVincent Pialoux
Vincent Pialoux
PHPatrick J. Hanly
Patrick J. Hanly
GFGlen E. Foster
Glen E. Foster
Julien BrugniauxJulien Brugniaux
Julien Brugniaux
ABAndrew E. Beaudin
Andrew E. Beaudin
MPMarc J. Poulin
Marc J. Poulin
Rationale: Periodic occlusion of the upper airway in patients with obstructive sleep apnea leads to chronic intermittent hypoxia, which increases the acute hypoxic ventilatory response (AHVR). Animal studies suggest that oxidative stress may modulate AHVR by increasing carotid body sensitivity to hypoxia. This has not been shown in humans. Objectives: To determine whether 4 days of exposure to chronic intermittent hypoxia increases AHVR and oxidative stress and to determine the strength of the association between oxidative stress and AHVR. Methods: After two normoxic control days (Day −4 and Day 0), 10 young healthy men were exposed awake to 4 days (Days 1–4) of intermittent hypoxia for 6 hours per day. Measurements and Main Results: AHVR, assessed using an isocapnic hypoxia protocol, was determined as the slope of the linear regression between ventilation and oxygen desaturation. Oxidative stress was evaluated by measuring plasma DNA, lipid and protein oxidation, uric acid and antioxidant status by measuring α-tocopherol, total vitamin C, and antioxidant enzymatic activities. Between baseline and Day 4, there were significant increases in AHVR, DNA oxidation, uric acid, and vitamin C, whereas antioxidant enzymatic activities and α-tocopherol were unchanged. There were strong correlations between the changes in AHVR and DNA oxidation (r = 0.88; P = 0.002). Conclusions: Chronic intermittent hypoxia increases oxidative stress by increasing production of reactive oxygen species without a compensatory increase in antioxidant activity. This human study shows that reactive oxygen species overproduction modulates increased AHVR. These mechanisms may be responsible for increased AHVR in patients with obstructive sleep apnea.

1 September 2010 in Hypertension
Verified
Journal Article
Closed access
GFGlen E. Foster
Glen E. Foster
PHPatrick J. Hanly
Patrick J. Hanly
SASofia B. Ahmed
Sofia B. Ahmed
ABAndrew E. Beaudin
Andrew E. Beaudin
VPVincent Pialoux
Vincent Pialoux
MPMarc J. Poulin
Marc J. Poulin
Intermittent hypoxia (IH) is believed to contribute to the pathogenesis of hypertension in obstructive sleep apnea through mechanisms that include activation of the renin-angiotensin system. The objective of this study was to assess the role of the type I angiotensin II receptor in mediating an increase in arterial pressure associated with a single 6-hour IH exposure. Using a double-blind, placebo-controlled, randomized, crossover study design, we exposed 9 healthy male subjects to sham IH, IH with placebo medication, and IH with the type I angiotensin II receptor antagonist losartan. We measured blood pressure, cerebral blood flow, and ventilation at baseline and after exposure to 6 hours of IH. An acute isocapnic hypoxia experimental protocol was conducted immediately before and after exposure to IH. IH with placebo increased resting mean arterial pressure by 7.9±1.6 mm Hg, but mean arterial pressure did not increase with sham IH (1.9±1.5 mm Hg) or with losartan IH (−0.2±2.4 mm Hg; P <0.05). Exposure to IH prevented the diurnal decrease in the cerebral blood flow response to hypoxia, independently of the renin-angiotensin system. Finally, in contrast to other models of IH, the acute hypoxic ventilatory response did not change throughout the protocol. IH increases arterial blood pressure through activation of the type I angiotensin II receptor, without a demonstrable impact on the cerebrovascular or ventilatory response to acute hypoxia.

12 January 2007 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
GFGlen E. Foster
Glen E. Foster
MPMarc J. Poulin
Marc J. Poulin
PHPatrick J. Hanly
Patrick J. Hanly

16 February 2015 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
PDPaolo B. Dominelli
Paolo B. Dominelli
JRJacqueline N. Render
Jacqueline N. Render
YMYannick Molgat-Seon
Yannick Molgat-Seon
GFGlen E. Foster
Glen E. Foster
LRLee M. Romer
Lee M. Romer
ASA. William Sheel
A. William Sheel

1 February 2007 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
LTLuc J. Teppema
Luc J. Teppema
GBGeorge M. Balanos
George M. Balanos
CSCraig D. Steinback
Craig D. Steinback
ABAllison D. Brown
Allison D. Brown
GFGlen E. Foster
Glen E. Foster
MPMarc Poulin
Marc Poulin
Rationale: Acute mountain sickness (AMS) may affect individuals who (rapidly) ascend to altitudes higher than 2,000–3,000 m. A more serious consequence of rapid ascent may be high-altitude pulmonary edema, a hydrostatic edema associated with increased pulmonary capillary pressures. Acetazolamide is effective against AMS, possibly by increasing ventilation and cerebral blood flow (CBF). In animals, it inhibits hypoxic pulmonary vasoconstriction. Objectives: We examined the influence of acetazolamide on the response to hypoxia of ventilation, CBF, and pulmonary vascular resistance (PVR). Methods: In this double-blind, placebo-controlled, randomized study, nine subjects ingested 250 mg acetazolamide every 8 h for 3 d. On the fourth test day, we measured the responses of ventilation, PVR, and CBF to acute isocapnic hypoxia (20 min) and sustained poikilocapnic hypoxia (4 h). Ventilation was measured with pneumotachography. Hypoxia was achieved with dynamic end-tidal forcing. The maximum pressure difference across the tricuspid valve (ΔPmax, a good index of PVR) was measured with Doppler echocardiography. CBF was measured by transcranial Doppler ultrasound. Results: In normoxia, acetazolamide increased ventilation and reduced ΔPmax, but did not influence CBF. The ventilatory and CBF responses to acute isocapnic hypoxia were unaltered, but the rise in ΔPmax was reduced by 57%. The increase in ΔPmax by sustained poikilocapnic hypoxia observed after placebo was reduced by 34% after acetazolamide, the ventilatory response was increased, but the CBF response remained unaltered. Conclusions: Acetazolamide has complex effects on ventilation, PVR, and CBF that converge to optimize brain oxygenation and may be a valuable means to prevent/treat high-altitude pulmonary edema.